Publications by authors named "Katie Kingston"
Article Synopsis
- * The study reviews various challenges and supports for starting buprenorphine treatment in the ED, highlighting the importance of teams and accessible services while pointing out issues like stigma and the complex needs of patients.
- * There's a call for better coordination in these efforts and the inclusion of diverse perspectives to create fairer pathways for starting opioid treatment in both the U.S. and Canada.
Introduction: Buprenorphine-naloxone is recommended as a first-line agent for the treatment of opioid use disorder. Although initiation of buprenorphine in the emergency department (ED) is evidence based, barriers to implementation persist. A comprehensive review and critical analysis of both facilitators of and barriers to buprenorphine initiation in ED has yet to be published.
View Article and Find Full Text PDF